New pill aims to shrink fatty liver in 12 weeks

NCT ID NCT07198386

First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 28 times

Summary

This study tests a new tablet, CS060380, for non-alcoholic steatohepatitis (NASH), a serious liver condition. About 120 adults will take the drug or a placebo daily for 12 weeks. Researchers will measure changes in liver fat using MRI and track any side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NASH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ruian People's Hosptial

    RECRUITING

    Wenzhou, Zhejiang, China

    Contact

  • Ruijin Hospital, Shanghai Jiaotong University School of Medicine

    NOT_YET_RECRUITING

    Shanghai, Shanghai Municipality, China

    Contact

  • The Affiliated Hospital of Hangzhou Normal University

    RECRUITING

    Hangzhou, Zhejiang, 311121, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Fifth People's Hospital of Suzhou

    RECRUITING

    Suzhou, Jiangsu, China

    Contact

  • The First Affiliated Hospital of Fujian Medical University

    NOT_YET_RECRUITING

    Fuzhou, Fujian, China

    Contact

  • Xiamen Hospital of T.C,M.

    RECRUITING

    Xiamen, Fujian, China

    Contact

  • Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine

    NOT_YET_RECRUITING

    Shanghai, Shanghai Municipality, China

    Contact

  • Zhongshan Hospital Fudan University

    RECRUITING

    Shanghai, Shanghai Municipality, China

    Contact

Conditions

Explore the condition pages connected to this study.